2-Chloro-N-((tetrahydro-2H-pyran-4-yl)methyl)nicotinamide

Catalog No. :
ACLREE634
CAS No. :
1220035-49-3
Molecular Formula :
C12H15ClN2O2
Molecular Weight :
254.72

IUPAC Name:2-chloro-N-((tetrahydro-2H-pyran-4-yl)methyl)nicotinamide

2-Chloro-N-((tetrahydro-2H-pyran-4-yl)methyl)nicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$139.00Login to see priceInquiryInquiry
5g95%$418.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-((tetrahydro-2H-pyran-4-yl)methyl)nicotinamide
IUPAC Name2-chloro-N-((tetrahydro-2H-pyran-4-yl)methyl)nicotinamide
MDL No.MFCD13562860
Molecular FormulaC12H15ClN2O2
Molecular Weight254.72
SMILESO=C(NCC1CCOCC1)C2=C(Cl)N=CC=C2
InChI KeyYGNIYXKPAXQEAB-UHFFFAOYSA-N
Synonym2-Chloro-N-(tetrahydro-2H-pyran-4-ylmethyl)-nicotinamide;3-Pyridinecarboxamide, 2-chloro-N-[(tetrahydro-2H-pyran-4-yl)methyl]-;Naringenin Impurity 10 Sodium Salt
CAS No.1220035-49-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLREE634 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBQVX036 route compound structure diagram
    ACBQVX036389621-78-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLREE634 route product structure diagram
    ACLREE6341220035-49-3
Inquiry

2. ACLREE634 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBQVX036 route compound structure diagram
    ACBQVX036389621-78-7 In Stock
  2. Plus
  3. ACCOGW615 route compound structure diagram
    ACCOGW61549609-84-9 In Stock
  4. Then
  5. ACLREE634 route product structure diagram
    ACLREE6341220035-49-3
Inquiry

Comments (0)